Guiding aerosol deposition in the lung

New England Journal of Medicine

Volumn 358, Issue 3, 2008, Pages 304-

  Coates, Allan L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

AEROSOL; ARTICLE; BRONCHOSCOPE; BRONCHUS DISEASE; DIFFUSION; DRUG DELIVERY SYSTEM; HUMAN; LUNG; MAGNETIC FIELD; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL;

EID: 38349081527     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr0707489     Document Type: Article

References (5)

1. Dames P, Gleich B, Flemmer A, et al. Targeted delivery of magnetic aerosol droplets to the lungs. Nat Nanotechnol 2007;2:495-9.
2. Coates AL, O'Callaghan C. Drug administration by aerosol in children. In: Chernick V, Boat TE, Wilmott RW, Bush A, eds. Kendig's disorders of the respiratory tract in children. Philadelphia: Saunders Elsevier, 2006:268-79.
3. Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Targeting aerosol deposition in patients with cystic fibrosis: effects of alteration in particle size and inspiratory flow rate. Chest 2000;118:1069-76.
4. Smaldone GC, Fuhrer J, Steigbigel RT, McPeck M. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1991;143:727-37.
5. Koehler DR, Frndova H, Leung K, et al. Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med 2005;7:1409-20.